Illumina has recently advanced its plan to divest its cancer-diagnostics unit, a move intended to ease regulatory pressure and sharpen its focus on core DNA sequencing and microarray technologies.
Dublin, Oct. 26, 2017 (GLOBE NEWSWIRE) -- The "Forensic Technology Market Analysis by Type (PCR, Capillary Electrophoresis, Next-Generation Sequencing, Rapid DNA Analysis, Microarrays), by Services, ...
Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. In 1976, workers excavating a tunnel for the Toronto subway system ...
A single genetic test could potentially replace the current two-step approach to diagnosing rare developmental disorders in children. This shift could enable earlier diagnoses for families and save ...
Perhaps no technology better embodies the spirit of the post-genomics age than the microarray. If genome sequencing projects listed the parts that make up an organism – be it a mouse, a fly, or a ...
Genomic testing based on chromosome microarray (CMA) and Next Generation Sequencing (NGS) revolutionized clinical genetics. That said, microarray, targeted panel, exome and generic whole genome ...
A single genetic test could potentially replace the current two-step approach to diagnosing rare developmental disorders in children. This shift could enable earlier diagnoses for families and save ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback